Jazz Pharma Profit Rises - Quick Facts

(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) Tuesday reported second-quarter net income of $42 million or $0.69 per share, compared with $27 million or $0.45 per share last year.

Excluding items, adjusted earnings for the quarter were $88 million or $1.43 per share, compared with $66 million or $1.09 per share a year ago.

Revenues for the quarter were $208 million, compared with $124 million in the prior year.

Analysts polled by Thomson Reuters estimated earnings of $1.52 per share on revenues of $208.71 million for the quarter. Analysts' estimates typically exclude special items.

For fiscal year 2013, Jazz revised its outlook and now expects net earnings of $3.26 to $3.55 per share, adjusted earnings of $6.20 to $6.40 per share, and revenues of $860 million to $$880 million. It earlier expected net earnings of $3.32 to $3.69 per share, adjusted earnings of $6.10 to $6.30 per share, and revenues of $830 million to $860 million.

Analysts currently expect earnings of $6.21 per share on revenues of $852.86 million for 2013.